EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeted Delivery of Microneurotrophin BNN27 via Biomaterial Grafts Protects Retinal Ganglion Cells After Optic Nerve Injury

K Georgelou iD, E A Saridaki, C P Apostolidou iD, X Mallios, A Papagiannaki iD, K Karali iD, T Katsila iD, T Calogeropoulou iD, A Mitraki iD, D Karagogeos iD, I Charalampopoulos iD, A Gravanis iD und 2 weitere

Journal of Biomedical Materials Research Part B: Applied Biomaterials · 2026

DOI: 10.1002/jbmb.70013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biomedical Materials Research Part B: Applied Biomaterials, 2026. Verfasst von K Georgelou und 13 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Molecular Biology and Biotechnology, Foundation for Research and Technology - Hellas, Heraklion, Greece. Hauptthemen laut MEDLINE: Optic Nerve Injuries, Retinal Ganglion Cells, Neuroprotective Agents, Biocompatible Materials. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hellenic Foundation for Research and Innovation (HFRI) and the General Secretariat for Research and Technology (GSRT), Greek State Scholarships Foundation, Hellenic Foundation for Research and Innovation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Emerging neurotrophin treatments for optic nerve injury (ONI) aim to prevent the loss of retinal ganglion cells (RGCs) and enhance axonal regeneration. Microneurotrophins (MNTs), small‐molecule mimetics of neurotrophins, have shown neuroprotective effects in various animal models of neurodegeneration, yet MNT effects on ONI remain unknown. Here, we study the effects of BNN27, a MNT that mimics NGF, in a mouse model of optic nerve crush (ONC) and compare the targeted administration via biomaterial grafts placed around the ONC lesion against standard eye drop delivery. Compared to eye drop delivery, targeted biomaterial‐based BNN27 delivery resulted in more consistent and efficient RGC neuroprotection and reduced microglia‐mediated inflammation in the ONC lesion. Our findings demonstrate that targeted delivery of MNTs can alleviate key consequences of ONI and, therefore, be an essential part of effective combinatorial ONI treatments.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Optic Nerve InjuriesRetinal Ganglion CellsNeuroprotective AgentsBiocompatible MaterialsNerve Growth FactorsAnimalsMiceMice, Inbred C57BLDisease Models, AnimalDrug Delivery SystemsMale

Stichwörter der Autor:innen

biomaterial graftsmicroneurotrophinsneuroprotectionoptic nerve injurytargeted delivery

Substanzen

Neuroprotective AgentsBiocompatible MaterialsNerve Growth Factors

Autor:innen und Institutionen

  • Institute of Molecular Biology and Biotechnology, Foundation for Research and Technology - Hellas, Heraklion, Greece.
  • Department of Pharmacology, School of Medicine, University of Crete, Heraklion, Greece.
  • Department of Materials Science and Engineering, University of Crete, Heraklion, Greece.
  • Institute of Electronic Structure and Laser, Foundation for Research and Technology - Hellas, Heraklion, Greece.
  • Institute of Chemical Biology, National Hellenic Research Foundation, Athens, Greece.
  • Department of Basic Science, School of Medicine, University of Crete, Heraklion, Greece.

ORCID-Profile: K Georgelou, C P Apostolidou, A Papagiannaki, K Karali, T Katsila, T Calogeropoulou, A Mitraki, D Karagogeos, I Charalampopoulos, A Gravanis, M Savvaki, D S Tzeranis

Förderung

  • Hellenic Foundation for Research and Innovation (HFRI) and the General Secretariat for Research and Technology (GSRT)
  • Greek State Scholarships Foundation
  • Hellenic Foundation for Research and Innovation

Zitieren

APA

Georgelou, K., Saridaki, E. A., Apostolidou, C. P., Mallios, X., Papagiannaki, A., Karali, K., Katsila, T., Calogeropoulou, T., Mitraki, A., Karagogeos, D., Charalampopoulos, I., Gravanis, A., Savvaki, M., & Tzeranis, D. S. (2026). Targeted Delivery of Microneurotrophin BNN27 via Biomaterial Grafts Protects Retinal Ganglion Cells After Optic Nerve Injury. Journal of Biomedical Materials Research Part B: Applied Biomaterials. https://doi.org/10.1002/jbmb.70013

Vancouver

Georgelou K, Saridaki EA, Apostolidou CP, Mallios X, Papagiannaki A, Karali K, et al. Targeted Delivery of Microneurotrophin BNN27 via Biomaterial Grafts Protects Retinal Ganglion Cells After Optic Nerve Injury. Journal of Biomedical Materials Research Part B: Applied Biomaterials. 2026. doi:10.1002/jbmb.70013

BibTeX
@article{Georgelou2026,
  author = {Georgelou, K and Saridaki, E A and Apostolidou, C P and Mallios, X and Papagiannaki, A and Karali, K and Katsila, T and Calogeropoulou, T and Mitraki, A and Karagogeos, D and Charalampopoulos, I and Gravanis, A and Savvaki, M and Tzeranis, D S},
  title = {Targeted Delivery of Microneurotrophin BNN27 via Biomaterial Grafts Protects Retinal Ganglion Cells After Optic Nerve Injury},
  journal = {Journal of Biomedical Materials Research Part B: Applied Biomaterials},
  year = {2026},
  doi = {10.1002/jbmb.70013}
}
Kostenlos starten →